Minimally Invasive Delivery of the Mitral Touch and 1-Year Follow-Up of the ENRAPT-MR Study will be Presented at EACTS 2019 Techno College

Tuesday, September 24, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

The Mitral Touch Represents a Breakthrough in the Surgical Treatment of Heart Failure

MORGAN HILL, Calif., Sept. 24, 2019 /PRNewswire-PRWeb/ -- The Mitral Touch is an epicardial clip designed to reduce mitral

regurgitation and provide subvalvular support of the left ventricle for functional mitral regurgitation (FMR) patients. The ENRAPT-MR study investigated the safety and performance of the Mitral Touch during concomitant treatment of FMR in patients already scheduled for coronary artery bypass surgery. The 1-Year durability of MR and LV reduction will be presented.

The minimally invasive delivery of the Mitral Touch would provide a stand-alone option for treating FMR in heart failure patients. Dr. Gan H. Dunnington, of Adventist Health in Santa Rosa, CA, and Dr. Isaac George, Associate Professor of Medicine and Surgical Director of the Heart Valve Center at Columbia University Medical Center, New York, NY, are championing this mini-thoracotomy (Mini-T) approach. Dr. Dunnington's presentation will include the progress to date on a beating heart cadaver model.

Dr. Dunnington summarized his perspective on the Mitral Touch: "I have dedicated my career to provide patients minimally invasive options, especially my AFib patients. The opportunity to provide a dedicated option for my FMR and heart failure patients would be a significant leap forward."

Dr. George added, "the recent surgical and interventional trials have made it clear, we need tools to treat both the MR and the LV, in order to help the FMR patient. A design that delivers both would be a big advance all by itself, but to do it in a procedure that does not require open heart surgery or a sternotomy would be welcome by both surgeons and patients alike."

The EACTS Techno College session is at The European Association for Cardio-Thoracic Surgery's (EACTS) annual meeting on Friday the 4th. The presentation, titled "Epicardial mitral repair system with minimally invasive access (beating heart cadaver)," is a component of the 8:00 – 11:15 Session.

About EACTS The European Association for Cardio-Thoracic Surgery was founded in 1986 as a European organization devoted to the practice of cardio-thoracic surgery. EACTS global membership includes 4000 surgeons, perfusionists and allied health professionals.

About Mitre Medical Corp. Mitre Medical is a medical device company with headquarters in Silicon Valley. The focus of the company is the development of innovative solutions to treat structural heart disease, including the Mitral Touch device. The Mitral Touch device is currently not approved by the FDA and is not CE marked.


SOURCE Mitre Medical Corp.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z



Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store